Register for free to listen to this article
Listen with Speechify
0:00
1:00
Sartorius Stedim Biotech
 

Sartorius Stedim Biotech has launched the first commerciallyavailable membrane adsorber for hydrophobic interaction chromatography (HIC).Sartobind Phenyl membrane adsorbers allow increased flow rates to ensure fasterprocesses and can be used for process upgrades in purification and polishing oftherapeutic proteins. Sartobind Phenyl provides the advantages of an HIC ligandadsorber while showing the specificity and behavior of a conventional HICmatrix. The hydrophobic phenyl ligand is covalently attached to the >3 µmcellulose membrane. Target molecules bind to the membrane with similar bindingcapacities and at the same buffer conditions as with conventional HIC columns.However, the flow rates can be increased at least tenfold to allow a fasterprocess upgrade in purification and polishing of therapeutic proteins. Theresolution is at least as good as that obtained with comparable phenyl columns.With a binding capacity of 0.4 mg/cm² (15 mg/ml), Sartobind Phenyl can be usedfor antibody medium scale capture. Its key application is removal ofhydrophobic aggregates that pose the risk of unwanted immune system responsewhen patients are treated with therapeutic proteins. Detergent removal andlarge molecule /bioparticle purification are further application options forHIC membranes. The membrane adsorber is easy to handle, suitable for single andbatch use and scalable from the 3 ml Sartobind nano version to the Sartobind150 ml capsule. It will soon also be scalable to the Jumbo 5 l unit.
 


Sartorius Stedim Biotech
 

Related Topics

Published In

Loading Next Article...
Loading Next Article...
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

An illustration of the tumor microenvironment, showing cancer cells, T cells, and nanoparticles interacting within a complex biological system

A closer look at the tumor microenvironment 

New technologies are allowing researchers to delve deeper into the complex tumor landscape.
An image of a western blot transfer showing the white, square transfer membrane with orange and blue bands representing the protein molecules undergoing transfer on a black and white machine.

Exploring stain-free western blotting

Researchers can achieve seamless western blot experiments by implementing advancements in stain-free technology, normalization methods, and compliance integration. 
A digital representation of a DNA double helix surrounded by molecular structures and chemical formulas.

Streamlining biopharmaceutical analysis with digital solutions

Discover how digitization improves data integrity and accelerates decision-making in biotherapeutics development. 
Drug Discovery News November 2024 Issue
Latest IssueVolume 20 • Issue 6 • November 2024

November 2024

November 2024 Issue

Explore this issue